Ryan Miller

Ryan Miller is an accomplished medical professional with extensive experience in clinical development, currently serving as the Head/Senior Medical Director at Amylyx Pharmaceuticals since April 2022, focusing on hyperinsulinemic hypoglycemia. Previously, Ryan held the role of Medical Director at Amylyx, specializing in ALS, and served as Medical Director at Biogen, where the focus was on Alzheimer’s Disease. Prior to these roles, Ryan worked as Associate Medical Director at Back Bay Life Science Advisors and as a Research Scientist/Engineer at the University of Washington from 2010 to 2014. Ryan holds a Doctor of Medicine (M.D.) from Boston University School of Medicine and a Bachelor of Science (BS) in Biological Sciences from the University of Washington.